信質集團(002664.SZ):葉小青累計增持1%股份
格隆匯2月23日丨信質集團(002664.SZ)公佈,2024年2月23日,公司收到中國證券登記結算有限責任公司深圳分公司下發的《持股5%以上股東每日持股變化明細》及葉小青女士的通知,獲悉葉小青女士自2024年2月19日至2024年2月23日通過深圳證券交易所繫統以集中競價交易方式累計增持公司股份4,059,000股,佔公司總股本的1%,增持金額合計為人民幣50,983,604元。本次增持後,葉小青女士持有公司43,809,000股,佔公司總股本10.77%,本次增持計劃的數量已過半且累計增持股份比例達到公司總股本的1%。葉小青女士增持計劃尚未實施完畢,後續將按照增持計劃,繼續擇機增持公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.